Aaron Franke MD MS

PubMed

• Re-ORIENT-ing antitumor immunity in EGFR-mutant non-small cell lung cancer: are antiangiogenics the key?
  Aaron J Franke, Erin L Schenk
  Chinese Clinical Oncology. 2023-06-01
• 4 citations
  Impact of Institutional Universal Microsatellite-Instability (MSI) Reflex Testing on Molecular Profiling Differences Between Younger and Older Patients with Colorectal...
  Ellery Altshuler, Aaron J Franke, William Paul Skelton 4th, Michael Feely, Yu Wang
  Clinical Colorectal Cancer. 2023-03-01
• 2 citations
  Extremely delayed-onset post-transplant lymphoproliferative disorder in a renal transplant patient.
  Ethan Holland, Ellery Altshuler, Aaron J Franke
  BMJ Case Reports. 2022-08-17

Abstracts/Posters

• Lorlatinib rescue therapy for life threatening CNS disease in crizotinib-resistant ROS1-positive NSCLC
  Franke AJ, Nair VS, Shafique M, Mokhtari S., Journal of Thoracic Oncology/2019 IASLC WCLC, Barcelona, Spain, 10/1/2019
• Predictive clinical and molecular features of long-term survivors receiving immune checkpoint inhibitors for stage 4 NSCLC.
  Franke AJ, Antonia SJ, Haura EB, Chiappori A, Tanvetyanon T, et al., Journal of Thoracic Oncology/IASLC 2019 WCLC, Barcelona, Spain, 10/1/2019
• Results of a phase II trial of the PARP inhibitor, niraparib, in BAP1 and other DNA damage response pathway deficient neoplasms.
  George TJ, Lee JH, Hosein PJ....... Franke AJ, et al., JCO/2022 ASCO Annual Meeting, Chicago, IL, 6/1/2022

Lectures

• Differences in the characteristics of younger and older MSI-H colorectal cancer (CRC) as determined by universal reflex testing. 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018